FCM
VERV

Farallon Capital Management’s Verve Therapeutics VERV Stock Holding History

Farallon Capital Management’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$40.6M Buy
3,612,000
+2,700,000
+296% +$30.3M 0.18% 54
2025
Q1 		$4.17M Buy
+912,000
New +$4.17M 0.02% 78
2023
Q4 		– Sell
-211,293
Closed -$2.8M – 164
2023
Q3 		$2.8M Buy
+211,293
New +$2.8M 0.01% 102